Discover Log In Sign Up
FMC
FMC Corporation
Summary
Earnings Call Analysis
Valuation
Profitability
Financial Health
Positive Attractive Price-to-Earnings Ratio
Positive Reasonable Price-to-Sales Ratio
Positive Strong Gross Profit Margin
Positive Solid Operating Profit Margin
Positive Strong Current and Quick Ratios
Positive Manageable Debt Levels
Positive πŸš€ Strong Focus on Core and Growth Portfolio
Positive πŸ’° Cost Reduction and Restructuring Success
Positive πŸ“ˆ Robust Product Pipeline
Positive 🌱 Growth Opportunities in New Markets
Positive πŸ”¬ Innovation Potential with New Active Ingredients
Positive πŸ“Š Strong Long-Term Financial Targets
Negative High EV/EBITDA Ratio
Negative Modest Net Profit Margin
Negative Low Cash Ratio
Negative πŸ“‰ Inventory Management Challenges
Negative ⚠️ Competitive Pressures from Generics
Negative ⏳ Short-Term Financial Performance Pressure
Negative πŸ’Έ FX Headwinds Impacting Profitability

FMC Corporation is positioned with a strong business model driven by a focus on core and growth portfolios, successful cost management, and a robust product pipeline. However, challenges in inventory management and increased competition from generics raise concerns about short-term performance. Looking ahead, there are promising growth opportunities linked to new products and market strategies, but the company may face pressures in the immediate future.

Analysis Date: February 4, 2025
Last Updated: March 12, 2025

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Graham Value Metrics

Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.

Intrinsic Value

Estimated fair value based on Graham's formula

$46.59

Current Market Price: $35.41

IV/P Ratio: 1.32x (>1.0 indicates undervalued)

Margin of Safety

Gap between intrinsic value and market price

24.0%

Graham recommended a minimum of 20-30% margin of safety

Higher values indicate a greater potential discount to fair value

Graham Criteria Checklist

Benjamin Graham's value investing checklist for FMC

Yes Positive earnings (5+ years)
Yes Dividend history (5+ years)
Yes P/E ratio ≀ 20 (13.00)
Yes P/B ratio ≀ 1.5 (0.99)
No Current ratio β‰₯ 2.0 (1.64x)
No Long-term debt < Net current assets (1.62x)
Yes Margin of safety (24.0%)
No FMC does not meet all Graham criteria

ROE: 7.5898075274682455

ROA: -0.1398745419752345

Gross Profit Margin: 38.951037422576015

Net Profit Margin: 8.028543840229858

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Strong Gross Profit Margin

38.95
Gross Profit Margin

FMC's gross profit margin of 38.95% indicates effective cost management and strong pricing power in its operations, which is a positive indicator of profitability.

Solid Operating Profit Margin

10.25
Operating Profit Margin

An operating profit margin of 10.25% demonstrates that FMC is able to retain a good portion of revenue after covering operational costs, reflecting efficient operations.

Modest Net Profit Margin

8.03
Net Profit Margin

The net profit margin at 8.03% indicates that while FMC is profitable, its ability to convert sales into actual profit is relatively modest compared to competitors.

About Profitability Metrics

Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.

Return on Equity (ROE)

Measures how efficiently a company uses its equity to generate profits

7.59%

10% 15%

Higher values indicate better returns for shareholders

TTM (as of 2025-04-16)

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

-0.14%

3% 7%

Higher values indicate better asset utilization

TTM (as of 2025-04-16)

Gross Profit Margin

Percentage of revenue retained after accounting for cost of goods sold

38.95%

20% 40%

Higher values indicate better efficiency in production

TTM (as of 2025-04-16)

Net Profit Margin

Percentage of revenue retained after accounting for all expenses

8.03%

8% 15%

Higher values indicate better overall profitability

TTM (as of 2025-04-16)

Strong Current and Quick Ratios

1.64
Current Ratio
1.24
Quick Ratio

FMC's current ratio of 1.64 and quick ratio of 1.24 indicate that the company has a strong liquidity position, suggesting it can easily meet its short-term obligations.

Manageable Debt Levels

0.78
Debt-to-Equity Ratio

With a debt-to-equity ratio of 0.78, FMC has a balanced approach to leveraging, which suggests a stable financial structure without excessive reliance on debt.

Low Cash Ratio

0.12
Cash Ratio

The cash ratio of 0.12 indicates that FMC has limited cash available to cover current liabilities, which may pose a risk if immediate liquidity is required.

About Financial Health Metrics

Financial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.

Debt to Equity Ratio

Total debt divided by total equity

0.78x

1.0x 2.0x

Lower values indicate less financial leverage and risk

Less than 1.0 is conservative, 1.0-2.0 is moderate, >2.0 indicates high risk

Q4 2024

Current Ratio

Current assets divided by current liabilities

1.64x

1.0x 2.0x

Higher values indicate better short-term liquidity

Less than 1.0 is concerning, 1.0-2.0 is adequate, greater than 2.0 is good

Q4 2024

πŸš€ Strong Focus on Core and Growth Portfolio

Expected to grow from 19% to 30% of total company sales by 2027.
Growth Portfolio Contribution

FMC is actively segmenting its products into core and growth portfolios, which allows for targeted strategies and better resource allocation. The company plans to leverage its core portfolio while investing in new active ingredients to drive future growth.

πŸ’° Cost Reduction and Restructuring Success

27.7%, an all-time Q4 high.
EBITDA Margin Q4 2024

The company exceeded its restructuring savings target, achieving $165 million in net savings for 2024, which has helped improve operating margins and create a more agile cost structure.

πŸ“ˆ Robust Product Pipeline

$600 million.
Projected Sales for New AIs by 2027

FMC has a strong pipeline of new active ingredients and formulations in development, which are expected to significantly contribute to sales growth. Products like fluindapyr and Isoflex are positioned well in the market.

πŸ“‰ Inventory Management Challenges

Expected to decline by 16% year-over-year.
Projected Revenue Decline Q1 2025

FMC has identified elevated inventory levels in various regions, particularly in LATAM and Asia, which could hinder sales growth in the short term as the company prioritizes reducing channel inventory.

⚠️ Competitive Pressures from Generics

3% in 2025, primarily due to contract adjustments.
Forecasted Price Decline

The upcoming patent expirations for key products like Rynaxypyr will lead to increased competition from generics, potentially impacting market share and pricing power.

🌱 Growth Opportunities in New Markets

Mid-20% range out to 2027.
Expected Growth Rate of Plant Health

The company is exploring new routes to market, especially in LATAM, which is expected to enhance its sales capabilities and customer reach, particularly with new products.

πŸ”¬ Innovation Potential with New Active Ingredients

Exceeds $2 billion.
Addressable Market for Fluindapyr

FMC's pipeline of new active ingredients, including Dodhylex and Isoflex, shows high potential for revenue growth and market expansion, especially in underserved segments.

πŸ“Š Strong Long-Term Financial Targets

$5.2 billion.
Projected 2027 Sales
23%.
Projected EBITDA Margin 2027

FMC has set ambitious targets for 2027, forecasting substantial growth in both revenue and EBITDA, indicating confidence in its strategic direction.

⏳ Short-Term Financial Performance Pressure

$870 million to $950 million.
Expected Full-Year EBITDA 2025

The aggressive inventory reduction strategies and necessary investments for new routes to market are expected to negatively impact financial performance in 2025, creating uncertainty in the short term.

πŸ’Έ FX Headwinds Impacting Profitability

$65 million to $75 million.
Estimated FX Headwind

FMC anticipates significant foreign exchange headwinds in 2025, which could further complicate its financial recovery and growth trajectory.

Home Screener Search Profile

During the beta period, we're currently displaying stocks from the S&P 500 index only. More stocks will be added soon.

Loading...